瑞普生物

- 300119

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
瑞普生物(300119) 利润表
单位:万元
报表日期2020-12-312020-09-302020-06-302020-03-312019-12-31
一、营业总收入200,040.71146,131.7092,432.8245,392.20146,658.05
营业收入200,040.71146,131.7092,432.8245,392.20146,658.05
二、营业总成本159,640.03112,565.5372,237.7935,681.82125,580.67
营业成本91,939.3663,851.7040,275.9919,536.8969,915.87
营业税金及附加1,844.091,260.12868.97382.231,782.37
销售费用35,634.2726,991.1017,528.538,949.3827,944.31
管理费用16,513.8011,035.977,547.724,113.3914,135.28
财务费用2,555.592,136.641,573.96827.482,323.60
研发费用11,152.927,290.004,442.611,872.439,479.24
资产减值损失----------
公允价值变动收益11,674.511,493.551,170.94620.526,821.76
投资收益151.22-3.1330.678.261,502.45
其中:对联营企业和合营企业的投资收益113.77-38.4016.440.06-139.57
汇兑收益----------
三、营业利润51,312.0133,386.3819,978.289,914.0326,306.74
加:营业外收入91.8670.9840.288.68191.87
减:营业外支出312.20214.2995.0978.90506.97
其中:非流动资产处置损失----------
四、利润总额51,091.6733,243.0719,923.479,843.8125,991.64
减:所得税费用7,142.614,612.632,984.891,375.523,611.77
五、净利润43,949.0628,630.4416,938.578,468.2822,379.86
归属于母公司所有者的净利润39,819.6525,226.8514,729.727,312.8619,435.99
少数股东损益4,129.403,403.602,208.861,155.422,943.87
六、每股收益
基本每股收益(元/股)1.00550.63760.37290.18520.4894
稀释每股收益(元/股)1.00550.63760.37290.18520.4894
七、其他综合收益----------
八、综合收益总额43,949.0628,630.4416,938.578,468.2822,379.86
归属于母公司所有者的综合收益总额39,819.6525,226.8514,729.727,312.8619,435.99
归属于少数股东的综合收益总额4,129.403,403.602,208.861,155.422,943.87
下载全部历史数据到excel中 返回页顶